BEVERLY CARTER: Open Payments
NPI 1558969253 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 13 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $1,302 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 6 | $344 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Novo Nordisk Inc | 1 | $121 |
| Lilly USA, LLC | 1 | $104 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $64 |
| Exact Sciences Corporation | 1 | $30 |
| Organon LLC | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: DAXXIFY, TEZSPIRE, Ozempic, ZEPBOUND, Winlevi, Cologuard Collection Kit, NEXPLANON, QULIPTA.
Industry payments across NM — which companies pay providers there.
